Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year...

Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal
Year 2009

SUNNYVALE, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced
that it will report results for its fourth quarter and fiscal year 2009, ended
June 27, 2009, on Monday, August 24, 2009 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PDT/ 5:00 p.m.
EDT and will be hosted by Euan S. Thomson, Ph.D., president and chief
executive officer and Derek Bertocci, senior vice president and chief
financial officer.

The conference call dial-in numbers are 1-800-901-5241 (USA) or 1-617-786-2963
(International), Conference ID: 78497690. In addition, a dial-up replay of the
conference call will be available beginning August 24, 2009 at 5:00 p.m.
PDT/8:00 p.m. EDT and ending on August 27, 2009. The replay telephone number
is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID:
53811638.

A live webcast of the call will also be available from the Investor Relations
section of the corporate Web site at http://www.accuray.com. A webcast replay
can be accessed on the corporate Web site beginning Monday, August 24, 2009 at
approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will remain available
until Accuray announces its results for the first quarter of fiscal 2010,
ending September 30, 2009.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global
leader in the field of radiosurgery dedicated to providing an improved quality
of life and a non-surgical treatment option for those diagnosed with cancer.
Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which
extends the benefits of radiosurgery to include extracranial tumors, including
those in the spine, lung, prostate, liver and pancreas. To date, the
CyberKnife System has been used to treat more than 60,000 patients worldwide
and currently more than 164 systems have been installed in leading hospitals
in the Americas, Europe and Asia. For more information, please visit
www.accuray.com.

SOURCE Accuray

Investors, Tom Rathjen, Vice President, Investor Relations, +1-408-789-4458,
trathjen@accuray.com, Media, Stephanie Tomei, Senior Manager, Public
Relations, +1-408-789-4234, stomei@accuray.com, both of Accuray